Clinical Trial Update: Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of acetylcysteine, paracetamol and phenylephrine for the common cold has been withdrawn. Sponsor: Sandoz.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Acetylcysteine (Acetylcysteine)
• Paracetamol (acetaminophen)
• Phenylephrine (phenylephrine)

Snippet

Sponsor: Sandoz | Conditions: Common Cold | Phase 3 | Status: WITHDRAWN